Search results for Pepfar

AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions

MONDAY, April 20, 2026 — New data released Friday show that President’s Emergency Plan for AIDS Relief (PEPFAR) treated about the same number of people in the last quarter of 2025...

Global Fund and U.S. Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates

With rollout underway in nine countries, early data indicate strong uptake among priority populations.

Surprising Data on the 2025 Impact of Global HIV Program PEPFAR

A State Department memo claims PEPFAR maintained HIV treatment rates in 2025. Here’s why AIDS advocates dispute that rosy tone.

<![CDATA[FDA Approves Foundayo Under National Priority Voucher Program]]>

Matt Erickson: Health aid cuts will weaken US diplomatic, economic efforts

The legacy of the President’s Emergency Plan for Aids Relief (PEPFAR) was nothing short of a miracle, saving over 26 million lives for less than 0.1% of the U.S. budget.

<![CDATA[WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain ]]>

Two startlingly different views on long-awaited data on America's anti-HIV efforts

After a year without data, the State Department released figures on PEPFAR, the program launched by George W. Bush and credited with saving millions of lives. How did Trump's aid c...

New PEPFAR Data Show Worrying Declines in Testing and Treatment for H.I.V.

The numbers are the first to quantify the effect of the Trump administration’s shutdown and restarting of a program that has saved millions of lives worldwide.

A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?

Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.

HIV experts horrified as Trump ends CDC support for PEPFAR programs: “PEPFAR… will crumble”

The administration plans to charge countries for CDC support services.

US voters support HIV/Aids relief – will Trump’s cuts backfire in the midterms?

Global Pepfar program has long had Republican leadership and bipartisan support, but initiative is under fire US midterm voters overwhelmingly support Pepfar, an initiative to end...

US is taking a ‘real risk’ with hasty shift in efforts to fight HIV, experts say

Experts fear losing ground to virus even as the end of the HIV epidemic is in sight, and say decline in infant testing is ‘particularly concerning’The US government released likely...

<![CDATA[FDA Approves Idvynso for Treatment of HIV-1 Infection in Adults]]>

<![CDATA[Pharmaceutical Executive Daily: WHO Identifies Priority Treatment Candidates for Ebola]]>

PrEP4All Files Federal Lawsuit Demanding Release of Secret HIV Prevention Agreement Between U.S. Government and Gilead

WASHINGTON, D.C. - TUESDAY, APRIL 28, 2026 - PrEP4All, the national nonprofit organization focused on expanding access to HIV prevention and the creation of a national federally-fu...

PrEP4All Files Federal Lawsuit Demanding Release of Secret HIV Prevention Agreement Between U.S. Government and Gilead

WASHINGTON, D.C. - TUESDAY, APRIL 28, 2026 - PrEP4All, the national nonprofit organization focused on expanding access to HIV prevention and the creation of a national federally-fu...

PrEP4All sues federal government over 2025 HIV prevention research agreement

As part of a years-long effort by PrEP4ALL and other HIV groups to get Gilead Sciences, a pharmaceutical company, to lower the cost of Truvada, which is used in pre-exposure prophy...

WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination

The World Health Organization (WHO) and Gilead Sciences have renewed their partnership through a new five-year agreement (2026–2030) to support the elimination of visceral leishman...